BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12057868)

  • 1. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
    Lung Cancer; 2002 Jul; 37(1):57-63. PubMed ID: 12057868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
    Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery.
    Chao Y; Li CP; Chau GY; Chen CP; King KL; Lui WY; Yen SH; Chang FY; Chan WK; Lee SD
    Ann Surg Oncol; 2003 May; 10(4):355-62. PubMed ID: 12734082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.
    Laack E; Köhler A; Kugler C; Dierlamm T; Knuffmann C; Vohwinkel G; Niestroy A; Dahlmann N; Peters A; Berger J; Fiedler W; Hossfeld DK
    Ann Oncol; 2002 Oct; 13(10):1550-7. PubMed ID: 12377642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer.
    Brattström D; Bergqvist M; Hesselius P; Larsson A; Wagenius G; Brodin O
    Lung Cancer; 2004 Jan; 43(1):55-62. PubMed ID: 14698537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
    Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
    Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
    Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
    Eur J Cancer Prev; 2002 Jun; 11(3):245-52. PubMed ID: 12131658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.
    Graeven U; Andre N; Achilles E; Zornig C; Schmiegel W
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):577-81. PubMed ID: 10473871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
    Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT
    Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma.
    Berglund A; Molin D; Larsson A; Einarsson R; Glimelius B
    Ann Oncol; 2002 Sep; 13(9):1430-7. PubMed ID: 12196369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer Lett; 2000 May; 153(1-2):7-12. PubMed ID: 10779624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
    Ugurel S; Rappl G; Tilgen W; Reinhold U
    J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
    Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.